ACIP meeting: CDC ‘scraping’ to respond to measles; FDA comments on Novavaxnews2025-04-15T23:28:26+00:00April 15th, 2025|Endpoints News|
Click Therapeutics gets FDA authorization for migraine treatmentnews2025-04-15T20:31:57+00:00April 15th, 2025|Endpoints News|
Biogen, Eisai’s Leqembi wins EU authorization for some patientsnews2025-04-15T19:42:35+00:00April 15th, 2025|Endpoints News|
Terumo Neuro Receives FDA Approval for Carotid Stent Systemnews2025-04-15T14:45:58+00:00April 15th, 2025|Medical Device News Magazine|
CDC vaccine advisors set to meet this week after two-month delaynews2025-04-14T19:39:55+00:00April 14th, 2025|Endpoints News|
AbbVie and Sandoz resolve court spat over Rinvoq patentsnews2025-04-14T19:22:34+00:00April 14th, 2025|Endpoints News|
FDA’s union readies negotiations with HHS over some fired staffnews2025-04-14T18:40:11+00:00April 14th, 2025|Endpoints News|
Sandoz sues Amgen over nearly decadelong launch delay for Enbrel biosimilarnews2025-04-14T17:32:12+00:00April 14th, 2025|Endpoints News|
Ironwood to look for alternative paths after FDA asks for another Phase 3news2025-04-14T12:40:17+00:00April 14th, 2025|Endpoints News|
FDA unveils plan to replace animal testing with organoidsnews2025-04-11T19:41:07+00:00April 11th, 2025|Endpoints News|